Cargando…
Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
Patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) have higher levels of immune activation, impaired antigen‐specific responses, and accelerated fibrogenesis compared to patients monoinfected with HCV. Whether different direct‐acting antiviral (DAA) combinations...
Autores principales: | Shrivastava, Shikha, Bhatta, Manasa, Ward, Haley, Romani, Sara, Lee, Rebecca, Rosenthal, Elana, Osinusi, Anu, Kohli, Anita, Masur, Henry, Kottilil, Shyam, Wilson, Eleanor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287478/ https://www.ncbi.nlm.nih.gov/pubmed/30556035 http://dx.doi.org/10.1002/hep4.1258 |
Ejemplares similares
-
CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients
por: Shrivastava, Shikha, et al.
Publicado: (2021) -
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
por: Tang, Lydia Shuk Yee, et al.
Publicado: (2016) -
Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014) -
Miliary Tuberculosis Coinfection with Human Immunodeficiency Virus
por: Esteve, Erika, et al.
Publicado: (2010) -
An Immunological Non-responder Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Patient: Considerations About a Clinical Case
por: Soares Correia, Rui, et al.
Publicado: (2023)